- Advertise
- OLE Scientific Interchange Workshops
- About OncLive
- Editorial Board
- CureToday.com
- TargetedOnc.com
- CancerNetwork.com
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2021 MJH Life Sciences™ and OncLive. All rights reserved.
Georgetown Lombardi Comprehensive Cancer Center | Strategic Alliance Partners
Latest from Georgetown Lombardi Comprehensive Cancer Center
The Marshalls Open a Candid Conversation About Cancer
April 01, 2021
Podcast
The Marshalls go beyond the pages of their new memoir, Off Our Chests: A Candid Tour Through the World of Cancer, to discuss how Liza's diagnosis of triple-negative breast cancer changed their lives and the key messages they hope readers will take from their book.
Dr. Gibney on the Potential for Fixed-Duration Immunotherapy in Melanoma
March 19, 2021
Video
Geoffrey T. Gibney, MD, discusses the potential utility of fixed-duration immunotherapy in melanoma.
Dr. Atkins on the FDA Approval of Tivozanib in Relapsed/Refractory Advanced RCC
March 16, 2021
Video
Michael B. Atkins, MD, discusses the FDA approval of tivozanib in relapsed/refractory advanced renal cell carcinoma.
The Marshall Family Faces Off Against TNBC
March 06, 2021
Article
Off Our Chests: A Candid Tour Through the World of Cancer is a memoir that dives into Liza Marshall’s breast cancer journey.
Dr. Atkins on the Efficacy of Dabrafenib/Trametinib in BRAF-Mutated Melanoma
March 01, 2021
Video
Michael B. Atkins, MD, discusses the efficacy of dabrafenib plus trametinib in patients with BRAF-mutated melanoma.
Dr. Gibney on Determining Optimal Treatment Duration With Anti–PD-1 Agents in Melanoma
February 26, 2021
Video
Geoffrey T. Gibney, MD, discusses efforts made to determine the optimal duration of treatment with anti–PD-1 agents in patients with melanoma.